Investigating Cytoskeletal Alterations as a Potential Marker of Retinal and Lens Drug-Related Toxicity
dc.contributor.author | Verdugo-Gazdik, Maria E. | en_US |
dc.contributor.author | Simic, Damir | en_US |
dc.contributor.author | Opsahl, Alan C. | en_US |
dc.contributor.author | Tengowski, Mark W. | en_US |
dc.date.accessioned | 2009-07-10T18:58:35Z | |
dc.date.available | 2009-07-10T18:58:35Z | |
dc.date.issued | 2006-12-01 | en_US |
dc.identifier.citation | Verdugo-Gazdik, Maria E.; Simic, Damir; Opsahl, Alan C.; Tengowski, Mark W. (2006). "Investigating Cytoskeletal Alterations as a Potential Marker of Retinal and Lens Drug-Related Toxicity." ASSAY and Drug Development Technologies 4(6): 695-707 <http://hdl.handle.net/2027.42/63132> | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/63132 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=17199508&dopt=citation | en_US |
dc.description.abstract | Actin filaments play a critical role in the normal physiology of lenticular and retinal cells in the eye. Disruption of the actin cytoskeleton has been associated with retinal pathology and lens cataract formation. Ocular toxicity is an infrequent observation in drug safety studies, yet its impact to the drug development process is significant. Recognizing compounds through screening with a potential ocular safety liability is one way to prioritize development candidates while reducing development attrition. Lens epithelial cells from human, dog, and rat origins and retinal pigmented epithelium cells from human, monkey, and rat origins were cultured and investigated with immunocytochemical techniques. Cells were treated using noncytotoxic doses of the compound, fixed, stained for actin with rhodamine phalloidin, and counterstained for nuclei with TOTO-3, followed by confocal imaging. Tamoxifen and several experimental compounds known to be in vivo lens and retinal toxicants caused a reduction in F-actin fluorescence at noncytotoxic concentrations in all cells tested as observed by confocal microscopy. Developing an assay that predicts ocular toxicity helps the development process by prioritizing compounds for further investigation. Drug-induced cytoskeletal alterations may be useful as a potential safety-screening marker of retinal and lens toxicity. The knowledge of actin molecular biology and the application of other mechanistic screens to toxicology are discussed. Reducing this work to a high-throughput platform will enable chemists to select compounds with a reduced risk of ocular toxicity. | en_US |
dc.format.extent | 375497 bytes | |
dc.format.extent | 2489 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.publisher | Mary Ann Liebert, Inc., publishers | en_US |
dc.title | Investigating Cytoskeletal Alterations as a Potential Marker of Retinal and Lens Drug-Related Toxicity | en_US |
dc.type | Article | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.identifier.pmid | 17199508 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/63132/1/adt.2006.4.695.pdf | |
dc.identifier.doi | doi:10.1089/adt.2006.4.695 | en_US |
dc.identifier.source | ASSAY and Drug Development Technologies | en_US |
dc.identifier.source | ASSAY and Drug Development Technologies | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.